Abstract
The metastasis of tumors to the stomach is rare, which underlies the clinical problems regarding their diagnosis and treatment. The present review summarizes the current knowledge regarding the clinicopathological characteristics, therapeutic strategies and outcomes for metastatic tumors in the stomach. The primary malignancies of the metastatic tumors in the stomach were most often breast cancers (27.9 %), followed by lung cancer (23.8 %), esophageal cancer (19.1 %), renal cell carcinoma (RCC; 7.6 %) and malignant melanoma (7.0 %). In cases of breast cancer and RCC as the primary malignancy, the median interval between the treatment of the primary tumor and diagnosis of the metastatic tumor in the stomach (IPM) was 50–78 and 75.6 months, respectively, highlighting the fact that the metastatic spread to the stomach may occur many years after the initial treatment of the cancer. In nine patients with metastatic gastric tumors arising from ovarian cancer, an endoscopic examination revealed submucosal tumors in six patients (66.7 %), with a median IPM of 30 months. Appropriate systemic treatment for these tumors is the preferred therapeutic strategy. Although solitary metachronous gastric metastasis several years after treatment of the primary tumor is an exceptionally rare event, surgical resection of metastatic gastric tumors may be recommended to control hemorrhaging or for selected tumors.
Similar content being viewed by others
References
Kobayashi O, Murakami H, Yoshida T, Cho H, Yoshikawa T, Tsuburaya A, et al. Clinical diagnosis of metastatic gastric tumors: clinicopathologic findings and prognosis of nine patients in a single cancer center. World J Surg. 2004;28:548–51.
De Palma GD, Masone S, Rega M, Simeoli I, Donisi M, Addeo P, et al. Metastatic tumors to the stomach: clinical and endoscopic features. World J Gastroenterol. 2006;12:7326–8.
Oda I, Kondo H, Yamao T, Saito D, Ono H, Gotoda T, et al. Metastatic tumors to the stomach: analysis of 54 patients diagnosed at endoscopy and 347 autopsy cases. Endoscopy. 2001;33:507–10.
Namikawa T, Munekage M, Kitagawa H, Okabayashi T, Kobayashi M, Hanazaki K. Metastatic gastric tumors arising from renal cell carcinoma: clinical characteristics and outcome of this uncommon disease. Oncol Lett. 2012;4:631–6.
Taal BG, Peterse H, Boot H. Clinical presentation, endoscopic features, and treatment of gastric metastases from breast carcinoma. Cancer. 2000;89:2214–21.
Namikawa T, Iwabu J, Kitagawa H, Okabayashi T, Kobayashi M, Hanazaki K, et al. Solitary gastric metastasis from a renal cell carcinoma, presenting 23 years after radical nephrectomy. Endoscopy. 2012;44:E177–8.
Namikawa T, Kobayashi M, Hanazaki K. Metastatic gastric tumor arising from ovarian cancer. Gastrointest Endosc (in press).
Antler AS, Ough Y, Pitchumoni CS, Davidian M, Thelmo W. Gastrointestinal metastases from malignant tumors of the lung. Cancer. 1982;49:170–2.
Saito T, Iizuka T, Kato H, Watanabe H. Esophageal carcinoma metastatic to the stomach. A clinicopathologic study of 35 cases. Cancer. 1985;56:2235–41.
Green LK. Hematogenous metastases to the stomach. A review of 67 cases. Cancer. 1990;65:1596–600.
Campoli PM, Ejima FH, Cardoso DM, Silva OQ, Santana Filho JB, Queiroz Barreto PA, et al. Metastatic cancer to the stomach. Gastric Cancer. 2006;9:19–25.
Ayantunde AA, Agrawal A, Parsons SL, Welch NT. Esophagogastric cancers secondary to a breast primary tumor do not require resection. World J Surg. 2007;31:1597–601.
Szynglarewicz B, Ekiert M, Forgacz J, Halon A, Skalik R, Matkowski R. The role of surgery in the treatment of colorectal metastases from primary skin melanoma. Colorectal Dis. 2012;14:e305–11.
Jung HJ, Lee HY, Kim BW, Jung SM, Kim HG, Ji JS, et al. Gastric metastasis from ovarian adenocarcinoma presenting as a submucosal tumor without ulceration. Gut Liver. 2009;3:211–4.
Akce M, Bihlmeyer S, Catanzaro A. Multiple gastric metastases from ovarian carcinoma diagnosed by endoscopic ultrasound with fine needle aspiration. Case Rep Gastrointest Med. 2012;2012:610527.
Kang WD, Kim CH, Cho MK, Kim JW, Lee JS, Ryu SY, et al. Primary epithelial ovarian carcinoma with gastric metastasis mimic gastrointestinal stromal tumor. Cancer Res Treat. 2008;40:93–6.
Schwarz RE, Klimstra DS, Turnbull AD. Metastatic breast cancer masquerading as gastrointestinal primary. Am J Gastroenterol. 1998;93:111–4.
Saunders NJ. Haematemesis due to gastric involvement by metastatic ovarian carcinoma 30 years after removal of the primary tumour. Br J Clin Pract. 1986;40:298–9.
Taylor RR, Phillips WS, O’Connor DM, Harrison CR. Unusual intramural gastric metastasis of recurrent epithelial ovarian carcinoma. Gynecol Oncol. 1994;55:152–5.
Sangha S, Gergeos F, Freter R, Paiva LL, Jacobson BC. Diagnosis of ovarian cancer metastatic to the stomach by EUS-guided FNA. Gastrointest Endosc. 2003;58:933–5.
Pernice M, Manci N, Marchetti C, Morano G, Boni T, Bellati F, et al. Solitary gastric recurrence from ovarian carcinoma: a case report and literature review. Surg Oncol. 2006;15:267–70.
Carrara S, Doglioni C, Arcidiacono PG, Testoni PA. Gastric metastasis from ovarian carcinoma diagnosed by EUS-FNA biopsy and elastography. Gastrointest Endosc. 2011;74:223–5.
Dassen AE, Lips DJ, Hoekstra CJ, Pruijt JF, Bosscha K. FDG-PET has no definite role in preoperative imaging in gastric cancer. Eur J Surg Oncol. 2009;35:449–55.
Ahmed K, Sussman JJ, Wang J, Schmulewitz N. A case of EUS-guided FNA-related pancreatic cancer metastasis to the stomach. Gastrointest Endosc. 2011;74:231–3.
Hassan H, Vilmann P, Sharma V. Impact of EUS-guided FNA on management of gastric carcinoma. Gastrointest Endosc. 2010;71:500–4.
Varadarajulu S, Eloubeidi MA. The role of endoscopic ultrasonography in the evaluation of pancreatico-biliary cancer. Surg Clin North Am. 2010;90:251–63.
Yamao K. Complications of endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNAB) for pancreatic lesions. J Gastroenterol. 2005;40:921–3.
Shah JN, Fraker D, Guerry D, Feldman M, Kochman ML. Melanoma seeding of an EUS-guided fine needle track. Gastrointest Endosc. 2004;59:923–4.
Paquin SC, Gariépy G, Lepanto L, Bourdages R, Raymond G, Sahai AV. A first report of tumor seeding because of EUS-guided FNA of a pancreatic adenocarcinoma. Gastrointest Endosc. 2005;61:610–1.
Chong A, Venugopal K, Segarajasingam D, Lisewski D. Tumor seeding after EUS-guided FNA of pancreatic tail neoplasia. Gastrointest Endosc. 2011;74:933–5.
Katanuma A, Maguchi H, Hashigo S, Kaneko M, Kin T, Yane K, et al. Tumor seeding after endoscopic ultrasound-guided fine-needle aspiration of cancer in the body of the pancreas. Endoscopy. 2012;44:E160–1.
Whithaus K, Fukuoka J, Prihoda TJ, Jagirdar J. Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung. Arch Pathol Lab Med. 2012;136:155–62.
Putti TC, Pinder SE, Elston CW, Lee AH, Ellis IO. Breast pathology practice: most common problems in a consultation service. Histopathology. 2005;47:445–57.
Chia SY, Thike AA, Cheok PY, Tan PH. Utility of mammaglobin and gross cystic disease fluid protein-15 (GCDFP-15) in confirming a breast origin for recurrent tumors. Breast. 2010;19:355–9.
McGregor DK, Khurana KK, Cao C, Tsao CC, Ayala G, Krishnan B, et al. Diagnosing primary and metastatic renal cell carcinoma: the use of the monoclonal antibody ‘Renal Cell Carcinoma Marker’. Am J Surg Pathol. 2001;25:1485–92.
Jones GE, Strauss DC, Forshaw MJ, Deere H, Mahedeva U, Mason RC. Breast cancer metastasis to the stomach may mimic primary gastric cancer: report of two cases and review of literature. World J Surg Oncol. 2007;5:75.
Suzaki N, Hiraki A, Ueoka H, Aoe M, Takigawa N, Kishino T, et al. Gastric perforation due to metastasis from adenocarcinoma of the lung. Anticancer Res. 2002;22:1209–12.
Sileri P, D’Ugo S, Blanco Gdel V, Lolli E, Franceschilli L, Formica V, et al. Solitary metachronous gastric metastasis from pulmonary adenocarcinoma: report of a case. Int J Surg Case Rep. 2012;3:385–8.
Abdulkader I, Sánchez L, Cameselle-Teijeiro J, Gude F, Chávez JE, López-López R, et al. Cell-cycle-associated markers and clinical outcome in human epithelial cancers: a tissue microarray study. Oncol Rep. 2005;14:1527–31.
Chung C, Christianson M. Predictive and prognostic biomarkers with therapeutic targets in breast, colorectal, and non-small cell lung cancers: a systemic review of current development, evidence, and recommendation. J Oncol Pharm Pract; 2013 Mar 14. (Epub ahead of print).
Conflict of interest
The authors have no conflicts of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Namikawa, T., Hanazaki, K. Clinicopathological features and treatment outcomes of metastatic tumors in the stomach. Surg Today 44, 1392–1399 (2014). https://doi.org/10.1007/s00595-013-0671-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00595-013-0671-9